if i recall telbivudine also was associated with CK elevation and rare myopathy - if share price takes a serious hit i wonder if this could be a buying opportunity.
Are you talking about the share price of VRUS, or IDIX? The Clevudine news is inconsequential for IDIX, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.